Harold Jacob - Dec 30, 2024 Form 4 Insider Report for NanoVibronix, Inc. (NAOV)

Role
Chief Medical Officer, Director
Signature
/s/ Harold Jacob, MD
Stock symbol
NAOV
Transactions as of
Dec 30, 2024
Transactions value $
$0
Form type
4
Date filed
1/2/2025, 09:20 PM
Previous filing
Feb 26, 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NAOV Option to Purchase Common Stock Award $0 +10K $0.00 10K Dec 30, 2024 Common Stock 10K $0.60 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% of the options vested on the date of grant in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2024 Long-Term Incentive Plan.